Introduction
============

Cataract is one of the most common causes of vision impairment and blindness all over the world. As the world's population ages, visual dysfunction and blindness induced by age-related cataract (ARC) are increasing. Since ARC is a multifactorial disease, environmental components and genetic predisposition contribute to the development of the pathological condition. Increased age and female gender are associated with an increased risk for all types of ARC. Current cigarette smoking is the most significant risk factor for nuclear cataracts; higher systolic blood pressure, a history of cigarette smoking, and a history of diabetes for cortical cataracts; higher systolic blood pressure for posterior subcapsular cataracts \[[@r1]\]. In addition, ultraviolet radiation exposure, sunlight exposure, drug ingestion, and lower body mass index are also risk factors for ARC \[[@r2],[@r3]\]. In the past few years, research into ARC has focused on the genetic factor and established that mutations that severely disrupt the lens cell architecture or environment might result in congenital cataracts, while relatively mild mutations might produce age-related cataract \[[@r4]\]. Strong evidence from twin studies has demonstrated the contribution of genetic factors in the pathogenesis of age-related cataract, a heritability of 53%--58% for cortical cataract and 48% for nuclear cataract \[[@r5],[@r6]\]. To date, many genetic studies have revealed variations or polymorphisms in genes may be associated with ARC \[[@r7]-[@r13]\].

Crystalline lens transparency is achieved and maintained by precise organized cell membrane domains and the cell--cell interactions. The ability to organize specialized membrane domains is essential to most cells, including the epithelial cells and the fiber cells of the lens. Mutations that severely disrupt it might produce congenital cataract and age-related cataract. Ezrin (encoded by the ezrin \[*EZR*\] gene) is a member of the ezrin/radixin/moesin (ERM) protein family. This protein serves as an intermediate between the plasma membrane and the actin cytoskeleton and has been implicated in various human cancers \[[@r14],[@r15]\]. Ezrin has a homologous amino acid domain called the FERM (4.1 protein/ezrin/radixin/moesin) domain, an α-helical region, and a carboxy-terminal ERM-associated domain (C-ERMAD) tail. This domain is involved in many important roles: maintenance of cell shape, cell mobility, and membrane trafficking \[[@r16]\]. In the lens, ezrin exists as part of the ezrin, periaxin, periplakin, and desmoyokin (EPPD) complex and is important in cell adhesive interactions and cell--cell junction of fiber cells. The EPPD complex plays an important role in the maintenance of lens structure and functions. The dysfunction of ezrin may cause aberrant lens development \[[@r17],[@r18]\]. Ezrin has specific cross-linking with Aquaporin 0 (AQP0). The interaction is between the C-terminus of AQP0 and the subdomains of ezrin. It is expected to occur only in new differentiating fiber cells because ezrin is degraded in the nucleus. This suggests that AQP0 may be a candidate ezrin-binding part in the EPPD complex and presumes the way that the EPPD complex links to the plasma membrane. Thus, reduction in or dysfunction of ezrin would potentially cause disorder of the fiber cells that induce opacification of the lens \[[@r19],[@r20]\]. Given this background, we chose *EZR* as a potential ARC candidate gene in this study.

To date, neither mutations in ezrin nor single nucleotide polymorphisms (SNPs) in *EZR* have been reported to be associated with cataract patients. In this case-control study, we screened all exons and the flanking region of *EZR* to investigate the genetic variations of ezrin and the relationship between SNPs in *EZR* and susceptibility to ARC in Chinese population.

Methods
=======

Participants and ethics statement
---------------------------------

Two hundred five patients with age-related cataracts and 218 unrelated healthy controls were recruited from the Second Affiliated Hospital Ophthalmic Clinic of Harbin Medical University ([Table 1](#t1){ref-type="table"}). Patients and controls were matched on gender (χ^2^ test, p=0.7027). Differences in age were adjusted with logistic regression.

###### Baseline Characteristics of the Study Subjects.

  **Group**   **Total**   **Male (%)**          **Female (%)**         **Mean Age(yo)**
  ----------- ----------- --------------------- ---------------------- ------------------
  Patients    205         94 (45.85)            111 (54.15)            71.59+8.18
  Controls    218         104 (47.71)           114 (52.29)            53.29±8.41
                          χ^2^ test, p=0.7027   *t* test, p=6.62e-75   

Cataract diagnosis was determined according to the Lens Opacities Classification System III (LOCSIII) \[[@r21]\]. All patients had bilateral cataracts, and the severity of the cortical or nuclear cataracts was greater than grade II. Patients with secondary cataracts due to trauma, toxins, inflammation, and degenerative ocular diseases were excluded from the study. In addition, patients who smoked, used alcohol, had exposure to ultraviolet B radiation, or took medication such as steroids and those with diabetes, hypertension, glaucoma, high myopia, and any other syndrome were not considered. Unrelated healthy individuals from the same ethnic background without a history of cataracts served as normal controls. The control subjects were selected randomly during a routine medical fitness examination, which included an ophthalmic examination. The bilateral lenses of the controls were all classified with LOCS grade 0.1. Written informed consent was obtained from all subjects after the nature and possible consequences of the study were explained. All experiments were approved by the Institutional Review Board of Harbin Medical University (Harbin, China) and conducted according to the principles in the Declaration of Helsinki.

Deoxyribonucleic acid isolation and genotyping
----------------------------------------------

Five milliliter samples of venous blood were collected in EDTA vacutainers (BD, San Jose, CA) from the patients with ARC and the control subjects. Genome DNA was extracted from peripheral blood leukocytes using the QIAamp DNA Blood Mini Kits (Qiagen Science, Germantown, MD). The primers ([Table 2](#t2){ref-type="table"}) for polymerase chain reaction (PCR) were designed using Primer3 according to the reference sequences in the NCBI Gene database. The PCR conditions were 95 °C for 4 min, followed by 35 cycles of 94 °C for 30 s, 55 °C for 30 s, 72 °C for 30 s, and a final extension step at 72 °C for 7 min. We sequenced the PCR products with the ABI3730 Automated Sequencer (PE Biosystems, Foster City, CA) and analyzed the sequencing results with Lasergene SeqMan (DNASTAR, Madison, WI).

###### Primers Used for Polymerase Chain Reaction (PCR) in This Study

  **Exon**   **Forward(5′-3′)**      **Rverse(5′-3′)**       **Amplicon Location(hg19)**
  ---------- ----------------------- ----------------------- -----------------------------
  Exon −1    TTCTGCTCTGACTCCAGGTTG   TGTGGTCGGAAGCCATCT      chr6:159238738--159239215
  Exon −2    GCCTCCTGAGACATCCC       TGAATCCGCCTGACTTT       chr6:159210069--159210587
  Exon −3    CTCCCATGGTTCTGTGTGTG    GAAGCAGACCAACACCCAAT    chr6:159208088--159208583
  Exon −4    GCCCCATTGAGTCTTGGTTA    GCATGAAGGAGCACTTGACA    chr6:159206216--159206706
  Exon −5    TGGCATAGCAAACTTCTC      TTAACTCGGTTCCCTCA       chr6:159205544--159206117
  Exon −6    GACTCTGCCTGTTTCACTC     ATTCTGCCTTCCTCTACC      chr6:159204304--159204728
  Exon −7    GGGAATGAACAGCAGAA       GACTATCACTGGCTACTCG     chr6:159197340--159197881
  Exon −8    ATTCCTAGTGCCGAGATGC     CTCCAGGGCTGACAACA       chr6:159192083--159192580
  Exon −9    ACCACGCTGGGATCTTC       TTCGGCTGTGAGTCTGC       chr6:159191665--159192155
  Exon −10   CGTTGGACGGGTTTCTAG      GGCAATCTTGGCAGTGTAT     chr6:159190415--159191189
  Exon −11   GCGGTGGATCAGATAAAGA     GCTGGTATTGGCAGAGGA      chr6:159190192--159190848
  Exon −12   CAGGACAGAGGGAGGTGA      ACATTAAGCAGCATTGGTCTA   chr6:159188116--159188633
  Exon −13   TCTAGTGAGGGCATCCG       TTCCGTAATTCAATCAGTCC    chr6:159187671--159188379

PolyPhen2 analysis
------------------

PolyPhen2 online software is a revised version of PolyPhen for annotating coding nonsynonymous SNPs on the function of encoded proteins by performing various sequence and structure analyses, yielding a probability of altered function. The software is based on the position-specific independent counts (PSIC) score derived from multiple sequence alignments of observations \[[@r22]\]. We used the data set HumDiv to test and train the predictions made by PolyPhen2. Predictions were characterized as either benign, possibly damaging, or probably damaging on the output. We downloaded the amino acid sequences from the NCBI HomoloGene database and evaluated the cross-species conservation of the nonsynonymous mutations with Lasergene MegAlign (DNASTAR).

Statistical analysis
--------------------

All the SNPs were validated with the NCBI SNP database and 1000 Genomes. The allele and genotype frequencies of the *EZR* SNPs were compared between the patients and controls. We evaluated the frequency of the genotypes and alleles in this study using the χ^2^ test and logistic regression. Paired SNP linkage disequilibrium analysis and haplotype analysis were performed as well. The risk for patients was estimated using the odds ratio (OR) and 95% confidence interval (CI). Statistical analysis was performed using SNPstats \[[@r23]\]. A p\<0.05 was considered statistically significant.

Results
=======

Characteristics of participants
-------------------------------

Two hundred five patients with age-related cataracts and 218 unrelated healthy controls were recruited in this study. The mean age of the cases was 71.59+8.18 years and that of controls was 53.29+8.41 years. In addition, the patients and controls were matched on gender (χ^2^ test, p=0.7027, [Table 1](#t1){ref-type="table"}). Differences in age were adjusted with logistic regression.

Identification of novel mutations and single nucleotide polymorphisms
---------------------------------------------------------------------

Three novel nucleotide changes, c.441C\>G, c.924G\>C, and c.1503G\>A in exon 4, exon 8, and exon 12, respectively, were found in the patients, and none presented in the normal controls ([Figure 1](#f1){ref-type="fig"}, [Table 3](#t3){ref-type="table"}). Among these changes, the nonsynonymous change c.924G\>C may lead to p.Q308H. Compared with the healthy controls, the [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286) -/GT genotype and - allele, [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318) T/C genotype and C allele, and [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) A/G genotype and G allele were observed with significantly higher frequencies in the patients with age-related cataract. The GT/GT genotype of [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286), the T/T genotype of [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318), and the A/A genotype of [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) were in all three patients in whom we found novel nucleotide changes. [Table 4](#t4){ref-type="table"} shows the distribution of the genotype and allele frequencies of [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286), [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318), and [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) in this study. The distributions of all SNPs were consistent with the Hardy--Weinberg equilibrium (HWE) in the control group. After the laboratory work, we reexamined the patients carrying mutations and confirmed the patients had no family history of cataracts.

![Mutation analysis of the *EZR* gene. The forward strand sequence chromatogram (**A**) shows the variation c.924G\>C we found in exon 8. The reverse strand sequence chromatograms (**B**, **C**) show the mutations c.1503G\>A in exon 12 and c.441C\>G in exon 4.](mv-v19-1572-f1){#f1}

###### Clinical Data of Patients Who Carried Genetic Variation

  **Serial number**   **Gender**   **Age(yo)**   **Type(both eyes)**   **Variation**   **Genotype**
  ------------------- ------------ ------------- --------------------- --------------- --------------
  A                   Female       72            Cortical              c.924G\>C       heterozygous
  B                   Female       57            Mix                   c.1503G\>A      heterozygous
  C                   Male         59            Nuclear               c.441C\>G       heterozygous

###### Distribution of the Genotype and Allele Frequencies of [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286), [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318) and [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) in the Patient and Control Group (adjusted by age).

  **SNP**                                                                            **Patient/control**   **Genotype N (%)**                            **Allele N (%)**                                
  ---------------------------------------------------------------------------------- --------------------- --------------------------------------------- ----------------------- ---------- ------------ ----------
  [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286)                             GT/GT                                         -/GT                    −/−        GT           \-
                                                                                     Patients              127 (62%)                                     78 (38%)                0 (0%)     332 (81%)    78 (19%)
                                                                                     Controls              180 (83%)                                     38 (17%)                0 (0%)     398 (91%)    38 (9%)
                                                                                                           p=0.0012 OR\*(95% CI^\#^)=3.37 (1.70--6.70)   χ^2^=18.98,p=3.96e-5                            
  [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318)                             T/T                                           T/C                     C/C        T            C
                                                                                     Patients              126 (61.5%)                                   75 (36.6%)              4 (2%)     327 (80%)    83 (20%)
                                                                                     Controls              180 (82.6%)                                   37 (17%)                1 (0.5%)   397 (91%)    39 (9%)
                                                                                                           p=0.0045 OR(95% CI)=3.40 (1.70--6.79)         χ^2^=21.86, p=8.82e-6                           
  [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330)                         A/A                                           A/G                     G/G        A            G
                                                                                     Patients              196 (95.6%)                                   9 (4.4%)                0 (0%)     401 (98%)    9 (2%)
                                                                                     Controls              217 (99.5)                                    1 (0.5%)                0 (0%)     435 (100%)   1 (0%)
                                                                                                           p=0.0472 OR(95% CI)=14.46 (1.29--162.43)      χ^2^=6.99, p=0.0244                             

\* Odds Ratio \# Confidence Interval p values were adjusted by Bonferroni Correction

Effects of nonsynonymous changes and cross-species conservation with in silico analysis
---------------------------------------------------------------------------------------

By using PolyPhen2, p.Q308H in *EZR* was predicted to be probably damaging. SNP [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) in exon 2, which causes the p.N6S substitution, was also predicted to be probably damaging by PolyPhen2. The scores and results of PolyPhen2 are listed in [Table 5](#t5){ref-type="table"}. We aligned the amino acid sequences of the *EZR* gene from several species. The glutamine at codon 308 in *EZR* was highly conserved ([Figure 2](#f2){ref-type="fig"}).

###### Variations Found in *EZR* and PolyPhen2 Results of the Nonsynonymous Mutations

  **Nucleotide notation**   **Protein notation**   **Polyphen2 score**   **Polyphen2 prediction**
  ------------------------- ---------------------- --------------------- --------------------------
  c.441C\>G                 synonymous             \-                    \-
  c.924G\>C                 p.Q308H                1.000                 Probably damaging
  c.1503G\>A                synonymous             \-                    \-
  c.17A\>G                  p.N6S                  0.992                 Probably damaging

![Cross-species conservation analysis. The black bars highlight the interesting positions of the proteins. Multiple alignments indicate that glutamine at codon 308 in ezrin is highly conserved.](mv-v19-1572-f2){#f2}

Paired single nucleotide polymorphism linkage disequilibrium analysis and haplotype analysis
--------------------------------------------------------------------------------------------

Paired SNP linkage disequilibrium analysis revealed that rs5881286 was in linkage disequilibrium with [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318) (D'\>0.75; [Figure 3](#f3){ref-type="fig"}). As shown in [Table 6](#t6){ref-type="table"}, haplotype association analysis denoted that the haplotype association including the - allele of [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286), the C allele of [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318), and the A allele of [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) exhibited significantly higher distribution in the patients compared to the normal controls (p=8.0e-4; OR=3.38; 95% CI=1.66--6.87).

![. Paired single nucleotide polymorphism linkage disequilibrium analysis. Paired SNP linkage disequilibrium analysis revealed that [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286) was in linkage disequilibrium with [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318) (D'\>0.75).](mv-v19-1572-f3){#f3}

###### Haplotype Association Analysis (adjusted by age).

  **rs5881286**   **rs2242318**   **rs144581330**   **Patient Frequency**   **Control Frequency**   **Odds Ratio**       **P Value**
  --------------- --------------- ----------------- ----------------------- ----------------------- -------------------- -------------
  GT              T               A                 0,766                   0,8376                  1                    ---
  \-              C               A                 0,1747                  0,0825                  3.38 (1.66--6.87)    8,00E-04
  GT              C               A                 0,0248                  0,0069                  2.77 (0.37--20.53)   0,32

Discussion
==========

Lens epithelial cell and fiber cell elongation and differentiation are associated with dramatic changes in cell morphology, membrane architecture, cortical cytoskeletal organization, and cell--cell adhesions. The ERM protein family is part of the band 4.1 superfamily that maintains the cell membrane domains. These proteins are expressed in a developmental and tissue-specific manner, with most epithelial cells predominantly expressing ezrin and endothelial cells predominantly expressing moesin. The proteins are involved in many important roles and can regulate the activities of the signal transduction pathways \[[@r24],[@r25]\].

The *EZR* gene consists of 13 exons. It encodes ezrin with 586 amino acids. Ezrin, similar to other ERM protein members, has a homologous amino acid domain called the FERM domain and terminates in the C-ERMAD as a tail \[[@r26]\]. The N-terminal FERM domain consists of three subdomains, named F1, F2, and F3 \[[@r27]\]. This domain followed by an approximate 150 residue region predicted to have a high α-helical content containing three helices (αA, αB, and αC) and characterized by assembly into a coiled-coil structure. Ezrin has a proline residue rich linker region and C-ERMAD, which contains the F-actin-binding site. As the plasma membrane--cytoskeleton linker, C-ERMAD binds with membrane proteins such as CD44 through an N-terminal FERM domain and connects to F-actin through a C-terminal domain.

The ezrin protein exists in a dormant, closed conformation as the binding of the FERM domain to the C-ERMAD. Therefore, the ligand binding sites, including F-actin and the scaffolding protein EBP50, are masked \[[@r28],[@r29]\]. Ezrin is activated through PtdIns (4, 5) P~2~ binding and phosphorylation of threonine 567, which reduces the affinity of the N-terminal FERM domain for C-ERMAD. The activation makes these functional domains ready for binding proteins. Studies focused on the structure of the ERM protein family proposed the α-helical domain of the family bends at the αA-αB junction and again at the αB-αC junction in a closed conformation. That causes the C-ERMAD to be positioned over F2 and F3 of the FERM domain \[[@r30],[@r31]\]. This indicates that the closed conformation and its activation are largely mediated by the central α-helical domain. Thus, the α-helical region is significant to the stability and activation of dormant ezrin monomers.

Another noticeable feature of ERM proteins is their ability to form homodimers or heterodimers \[[@r32]\]. It suggests dimers may consist of antiparallel subunits held together by two FERM/C-ERMAD associations \[[@r33]\]. This indicates that a parallel association in which the central α-helical region assembles a coiled-coil drives dimer formation yielding a molecule with two FERM domains on one end and two C-ERMADs on the other, linking from the membrane proteins to the cytoskeleton \[[@r34]\]. The coiled-coil formed by the α-helical region and the FERM/C-ERMAD associations are essential for dimer formation \[[@r35]\]. In addition, this region could serve as a binding site for associated molecules, including the regulatory subunit of protein kinase A, which provides specific regulation of plasma membrane pumps and channels located in the proximity of subplasmalemmal F-actin \[[@r36]\]. That means the mutation in this α-helical region could impact the ability of ezrin to be the nidus for the localization of critical regulatory enzyme systems, apart from linking the plasma membrane with the cytoskeleton. In our study, the mutation c. 924G\>C that resulted in a p.Q308H substitution is in the α-helical domain ([Figure 4](#f4){ref-type="fig"}). The amino acid affected by this mutation in the α-helical region evolutionarily is conserved at a high level. This mutation may impact the stability of the coiled-coil structure, affecting the release of the function region and the conformation of the ezrin monomer or dimer. However, the specific mechanism the mutation influences on ezrin is still unknown. Synonymous variations may still contribute to the development of human diseases \[[@r37]\]. Therefore, the synonymous mutations c.441C\>G and c.1503G\>A found in *EZR* may affect the normal process of translation.

![Genomic structure of the EZR exons, domain organization of ezrin and the identified mutation. The red parts indicate the UTR of the *EZR* gene, and the blue domains indicate the exons that are translated (upper panel). Ezrin consists of the FERM domain (composed of three subdomains, designated F1, F2, and F3), α-helical domain, linker region, and C-ERMAD (lower panel). The c.924G\>C in EZR exon 8 and the p.Q308H substitution in ezrin are traced at the bottom of the figure.](mv-v19-1572-f4){#f4}

In this study, we also investigated the association between gene *EZR* polymorphisms and the risk of age-related cataract in the Chinese population. We found a statistically significant difference in the *EZR* polymorphism frequencies between the patients and normal controls. The data show the polymorphisms of the -/GT genotype and the - allele of [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286), the T/C genotype and the C allele of [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318), and the A/G genotype and the G allele of [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) may be associated with an increased risk of cataract. In addition, the paired SNP linkage disequilibrium analysis revealed that [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286) was in linkage disequilibrium with [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318) and the haplotype association including the - allele of [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286), the C allele of [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318), and the A allele of [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) exhibited significantly higher distribution in patients than in controls. That meant the GT allele of [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286), the T allele of [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318), and the A allele of [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) may have a protective effect against the development of age-related cataract, particularly when the GT allele of [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286) and the T allele of [rs2242318](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2242318) are in one person.

In the past few years, several studies showed that variations in the untranslated region (UTR) were important to translational regulation \[[@r38]\]. The [rs5881286](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5881286) in the 3′ UTR of *EZR* potentially interferes with the process of candidate microRNA binding to the *EZR* gene, including hsa-miR-548u, hsa-miR-4744, hsa-miR-4801, and hsa-miR-4731--3p. This may impact the normal process of translation. This polymorphism could also lead to significant alteration of the secondary mRNA structure, forming a new loop-stem structure and affecting the stability of the secondary mRNA structure. The [rs144581330](http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=144581330) located in the coding region causes the p.N6S. It was predicted to be probably damaging by PolyPhen2. In addition, this amino substitution may affect the normal function of ezrin since its location is in the FERM domain. However, further studies are needed to find the precise mechanisms.

This is the first study of *EZR* and age-related cataract development in the Chinese population. No mutation in ezrin has been reported in age-related cataract or congenital cataract as a pathogenic gene before. The current knowledge of the highly conserved α-helical region in ezrin is rudimentary. Further study for a better understanding of this protein is still needed.
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